Inclusive
7078
Renascience
4889
Chordia Therapeutics
190A
Kufu Company Holdings
4376
Cube
7112
JP Stock MarketDetailed Quotes
4490 VisasQ
- 1077
- +17+1.60%
20min DelayMarket Closed Jan 9 15:30 JST
9.95BMarket Cap-0.77P/E (Static)
1080High1053Low28.00KVolume1080Open1060Pre Close29.86MTurnover188852wk High0.70%Turnover Ratio9.24MShares71552wk Low-1365.58EPS TTM4.32BFloat Cap7120Historical HighLossP/E (Static)4.01MShs Float715Historical Low-1404.57EPS LYR2.55%Amplitude--Dividend TTM19.54P/B100Lot Size--Div YieldTTM
VisasQ Key Stats
Quarterly+Annual
YOY
| (FY)Feb 29, 2024 | (FY)Feb 28, 2023 | (FY)Feb 28, 2022 | (FY)Feb 28, 2021 | (FY)Feb 29, 2020 | (FY)Feb 28, 2019 | (FY)Feb 28, 2018 | |
|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | |||||||
| Cash from operating activities | -19.27%1.31B | 413.95%1.62B | -21.43%315.66M | 182.88%401.77M | 177.00%142.03M | 229.95%51.27M | -39.45M |
| Net profit before non-cash adjustment | -28,028.33%-14.39B | 86.87%-51.17M | -297.62%-389.76M | 270.84%197.23M | 120.91%53.19M | 141.47%24.08M | ---58.05M |
| Total adjustment of non-cash items | 1,234.66%15.59B | 123.66%1.17B | 1,100.03%522.28M | 28.17%43.52M | 218.13%33.96M | 180.30%10.67M | --3.81M |
| -Depreciation and amortization | 12.38%1.27B | 339.50%1.13B | 1,299.88%256.19M | 17.22%18.3M | 67.53%15.61M | 194.35%9.32M | --3.17M |
| -Reversal of impairment losses recognized in profit and loss | --14.47B | --0 | ---- | ---- | ---- | ---- | ---- |
| -Disposal profit | --32.47M | --0 | --0 | --0 | --0 | --0 | ---1K |
| -Net exchange gains and losses | -51.56%-22.57M | -122.24%-14.89M | -378.74%-6.7M | 1,524.32%2.4M | 208.82%148K | 2.16%-136K | ---139K |
| -Other non-cash items | -376.49%-157.73M | -79.09%57.05M | 1,095.54%272.79M | 25.39%22.82M | 1,120.46%18.2M | 90.66%1.49M | --782K |
| Changes in working capital | -77.79%112.24M | 175.93%505.36M | 13.75%183.15M | 193.38%161.01M | 232.20%54.88M | 11.74%16.52M | --14.78M |
| -Change in receivables | -1,849.49%-356.09M | -135.23%-18.27M | 124.75%51.85M | -306.56%-209.5M | 28.07%-51.53M | -43.61%-71.64M | ---49.88M |
| -Change in inventory | ---- | ---- | ---- | ---- | ---- | 200.00%211K | ---211K |
| -Change in prepaid assets | -108.34%-2.62M | 167.51%31.45M | -512.78%-46.58M | 2,858.92%11.28M | 94.50%-409K | -95.58%-7.43M | ---3.8M |
| -Change in payables | -105.35%-9.19M | 177.00%171.6M | -299.46%-222.87M | 208.88%111.74M | -15.95%36.18M | 20.76%43.04M | --35.64M |
| -Change in accrued expense | -8.82%28.53M | 292.20%31.29M | -1,022.85%-16.28M | -89.16%1.76M | 632.01%16.28M | -66.37%2.22M | --6.61M |
| -Provision for loans, leases and other losses | 185.26%76.52M | -241.16%-89.75M | 22.39%63.58M | 447.42%51.95M | --9.49M | ---- | ---112K |
| -Changes in other current assets | -1.04%375.09M | 7.24%379.05M | 82.40%353.44M | 304.45%193.77M | 1.77%47.91M | 77.54%47.08M | --26.52M |
| -Changes in other current liabilities | ---- | ---- | ---- | ---- | -199.90%-3.04M | 13,709.09%3.04M | --22K |
| Dividends paid (cash flow from operating activities) | |||||||
| Dividends received (cash flow from operating activities) | |||||||
| Interest paid (cash flow from operating activities) | 17.17%-37.32M | -78.54%-45.05M | -198.04%-25.24M | -153.65%-8.47M | -119.75%-3.34M | -82.57%-1.52M | -832K |
| Interest received (cash flow from operating activities) | 96.30%53K | 12.50%27K | 41.18%24K | -48.48%17K | 266.67%33K | 800.00%9K | 1K |
| Tax refund paid | -636.85%-470.02M | -2.63%-63.79M | -30,976.50%-62.15M | -125.28%-200K | 125.67%791K | -515.92%-3.08M | 741K |
| Other operating cash inflow (outflow) | 2,427.86%130.29M | 92.60%5.15M | 267,700.00%2.68M | -1K | 0 | -300.00%-2K | 1K |
| Operating cash flow | -38.58%932.75M | 557.52%1.52B | -41.25%230.97M | 181.78%393.12M | 198.88%139.51M | 218.04%46.68M | ---39.54M |
| Investing cash flow | |||||||
| Net PPE purchase and sale | -30.55%-56.14M | -67.03%-43M | 5.22%-25.75M | -155.15%-27.16M | 52.74%-10.65M | -237.89%-22.53M | ---6.67M |
| Net intangibles purchase and sale | -11.59%-217.43M | -264.81%-194.85M | ---53.41M | ---- | ---- | ---- | ---- |
| Net business purchase and sale | --0 | 98.21%-197.84M | ---11.04B | ---- | ---- | ---- | ---- |
| Net changes in other investments | -781.70%-12.03M | 235.77%1.77M | 96.16%-1.3M | -45.08%-33.82M | 5.75%-23.31M | -8,103.24%-24.73M | --309K |
| Investing cash flow | 34.18%-285.6M | 96.10%-433.93M | -18,141.04%-11.12B | -79.59%-60.98M | 28.15%-33.95M | -643.27%-47.26M | ---6.36M |
| Financing cash flow | |||||||
| Net issuance payments of debt | 33.62%-325.44M | -112.49%-490.25M | 35,434.34%3.92B | 33.36%-11.11M | 0.00%-16.67M | -108.57%-16.67M | --194.44M |
| Net common stock issuance | 63.53%35.15M | -99.76%21.49M | 1,147.00%8.92B | --714.95M | ---- | ---- | ---- |
| Issuance fees | ---- | ---- | ---261.68M | ---- | ---2M | ---- | ---- |
| Net other fund-raising expenses | 0.00%1K | -100.00%1K | --65.94M | ---- | ---3.44M | ---- | ---- |
| Financing cash flow | 38.07%-290.29M | -103.71%-468.76M | 1,696.52%12.64B | 3,283.94%703.84M | -32.63%-22.11M | -108.57%-16.67M | --194.44M |
| Net cash flow | |||||||
| Beginning cash position | 24.06%3.88B | 130.09%3.12B | 318.94%1.36B | 34.60%324.07M | -6.64%240.76M | 136.17%257.87M | --109.19M |
| Current changes in cash | -42.07%356.86M | -64.85%615.98M | 69.17%1.75B | 1,141.42%1.04B | 583.86%83.45M | -111.61%-17.25M | --148.54M |
| Effect of exchange rate changes | -44.49%75.29M | 901.45%135.62M | 663.31%13.54M | -1,524.32%-2.4M | -208.82%-148K | -2.16%136K | --139K |
| Cash adjustments other than cash changes | 0.00%-1K | -200.00%-1K | --1K | ---- | -200.00%-1K | --1K | ---- |
| End cash Position | 11.15%4.31B | 24.06%3.88B | 130.09%3.12B | 318.94%1.36B | 34.60%324.07M | -6.64%240.76M | --257.87M |
| Free cash flow | -48.73%656.72M | 745.30%1.28B | -58.55%151.52M | 183.68%365.56M | 433.58%128.87M | 152.26%24.15M | ---46.21M |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |